Skip to main content
ACR
NYSE Real Estate & Construction

Stockholders Approve Highly Dilutive Merger Share Issuance and New Equity Plan

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: REIT Stocks · Real Estate
Sentiment info
Negative
Importance info
9
Price
$17.02
Mkt Cap
$121.371M
52W Low
$15.61
52W High
$24.61
52W Position info
9.0% above low
Off High info
31% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

ACR is trading near its 52-week low of $15.61 (9.0% above the low).

Summary

Shareholders approved the issuance of over 7.49 million shares for a merger, representing approximately 105% dilution, and a new equity plan authorizing an additional 1.43 million shares.


Key Events · Financing and Capital Events · ACR

  • Merger Share Issuance Approved

    Stockholders approved the issuance of approximately 7,487,219 shares of common stock for the internalization merger with ACRES Capital Corp. This approval finalizes a previously announced transaction and represents approximately 105% dilution to the current outstanding shares.

  • New Equity Incentive Plan Adopted

    The 2026 Omnibus Equity Incentive Plan was approved, authorizing the future issuance of up to 1,432,172 additional shares. This represents approximately 20% potential dilution if all authorized shares were issued.

  • Routine Annual Meeting Approvals

    Stockholders also re-elected nine directors, approved executive compensation in an advisory vote, and ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026.


Analysis · ACR · Real Estate & Construction

Stockholders have approved the issuance of approximately 7.49 million shares for the internalization merger with ACRES Capital Corp., which represents roughly 105% dilution to existing shareholders. This finalizes a major corporate event that was previously announced and discussed in proxy filings. Additionally, a new equity incentive plan was adopted, authorizing the future issuance of up to 1.43 million additional shares, representing approximately 20% potential dilution. These approvals significantly increase the company's share count and could exert substantial downward pressure on per-share metrics.

At the time of this filing, ACR was trading at $17.02 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $121.4M. The 52-week trading range was $15.61 to $24.61. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ACR - Latest Insights

ACR
Aug 07, 2026, 4:06 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $15.13
Real-time Price: $15.13 info
Change: $0 (0%) info
Market Cap: $107.894M info
ACR
Aug 06, 2026, 4:20 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $14.60
Real-time Price: $15.13 info
Change: +$0.530 (+4%) info
Market Cap: $107.894M info
ACR
Aug 04, 2026, 6:42 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $17.27
Real-time Price: $15.13 info
Change: -$2.14 (-12%) info
Market Cap: $107.894M info
ACR
Aug 04, 2026, 6:40 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $17.27
Real-time Price: $15.13 info
Change: -$2.14 (-12%) info
Market Cap: $107.894M info
ACR
Jul 29, 2026, 4:24 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.30
Real-time Price: $15.13 info
Change: -$3.17 (-17%) info
Market Cap: $107.894M info